BRIEF published on 05/07/2025 at 17:54, 1 year 2 months ago SKAN Group AG Annual Meeting: All Board Proposals Approved Dividend Distribution Board Re-election Non-Financial Matters Remuneration Report SKAN Group AGM
PRESS RELEASE published on 05/07/2025 at 17:49, 1 year 2 months ago Annual General Meeting of SKAN Group AG approves all proposals Annual General Meeting of SKAN Group AG approves all proposals at their meeting in Allschwil, Switzerland. Board members re-elected and dividend distribution approved Annual General Meeting Board Members Dividend Distribution SKAN Group AG Allschwil
BRIEF published on 03/25/2025 at 06:05, 1 year 4 months ago SKAN Records Significant Profit and Order Growth in 2024 Sustainability Strategy Order Intake Increase EBITDA Margin Expansion SKAN Group Financial Growth Future Growth Investments
PRESS RELEASE published on 03/25/2025 at 06:00, 1 year 4 months ago SKAN with significant profit increase and strong order intake in the 2024 financial year SKAN reports significant profit increase and strong order intake in the 2024 financial year, with growth in order intake, net sales, and EBITDA. Dividend proposed at CHF 0.40 per share Financial Year Dividend Order Intake Profit Increase SKAN
BRIEF published on 01/22/2025 at 07:05, 1 year 6 months ago SKAN Reports Preliminary Figures for 2024 EBITDA Pharmaceutical Industry Net Sales SKAN Group AG 2024 Financial Figures
PRESS RELEASE published on 01/22/2025 at 07:00, 1 year 6 months ago SKAN announces preliminary key figures for the 2024 financial year SKAN Group AG announces preliminary key figures for the 2024 financial year revealing increased net sales and EBITDA. Detailed financial results will be released on March 25, 2025 EBITDA Net Sales 2024 Financial Year SKAN Group AG Preliminary Key Figures
BRIEF published on 08/20/2024 at 07:05, 1 year 11 months ago SKAN Group Reaches Its Targets in the First Half of 2024 Profitability Net Sales Growth Order Intake Half-year Results SKAN Group
PRESS RELEASE published on 08/20/2024 at 07:00, 1 year 11 months ago SKAN Group reaches its targets in the first half of 2024 SKAN Group AG achieves targets with net sales growth of 17.2% and EBITDA increase of 15.7% in the first half of 2024. Strong order intake and backlog, confirming guidance for full year Net Sales Growth Order Intake EBITDA Increase Guidance SKAN Group
BRIEF published on 05/31/2024 at 07:05, 2 years 2 months ago SKAN Increases Stake in Aseptic Technologies to 90 Percent Pharmaceutical Industry Stake Increase SKAN Aseptic Technologies AT-Closed Vial®
PRESS RELEASE published on 05/31/2024 at 07:00, 2 years 2 months ago SKAN increases stake in Aseptic Technologies to 90 percent SKAN Group AG increases its stake in Aseptic Technologies to 90%, reinforcing strategic importance. Aseptic Technologies specializes in AT-Closed Vial® Technology for cell and gene therapy applications Pharmaceutical Industry Stake Increase SKAN Group AG Aseptic Technologies AT-Closed Vial® Technology
Published on 08/01/2026 at 01:20, 2 days 21 hours ago Gamma Resources Announces $880,000 Private Placement with Full Warrant Coverage
Published on 08/01/2026 at 01:15, 2 days 21 hours ago Clean Air Metals and Fiore-Backed Springbok Ventures Announce Strategic Business Combination
Published on 08/01/2026 at 00:30, 2 days 22 hours ago Battery X Metals Announces Amendment to Corporate Awareness Engagement
Published on 07/31/2026 at 23:20, 2 days 23 hours ago Pentagon I Capital Corp. Announces Conditional Acceptance of Qualifying Transaction with Prospectiva Resources Ltd.
Published on 08/03/2026 at 21:39, 1 hour 1 minute ago PAUL Tech AG reports net income after tax of EUR 3.2 million for fiscal year 2025 and issues a positive outlook for fiscal year 2026
Published on 08/03/2026 at 19:35, 3 hours 5 minutes ago Enzene Launches NeX™, a Comprehensive Suite of Solutionsto Enable Cost-Efficient, High-Yielding Local Biomanufacturing
Published on 08/03/2026 at 19:01, 3 hours 39 minutes ago EQS-Adhoc: Fresenius Medical Care AG : Fresenius Medical Care reports operating income excluding special items to be above market expectations in Q2 2026 and confirms its outlook for the financial year 2026
Published on 08/03/2026 at 18:45, 3 hours 55 minutes ago Covivio - Information on total number of voting rights and share capital
Published on 08/03/2026 at 17:45, 4 hours 55 minutes ago Monthly disclosure of the total number of shares and voting rights - July 2026
Published on 08/03/2026 at 17:40, 5 hours ago Eiffage announces the end of exclusive negotiations with Atlas Arteria for the possible acquisition of the Warnow Tunnel concession in Rostock, Germany
